zinc finger with KRAB and SCAN domains 7 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored ZKSCAN7P1 profile across patient tissues and cancer cell-line models. ZKSCAN7P1 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, ZKSCAN7P1 is differentially expressed in 2, with the highest sampling consensus in BRCA. Additionally, ZKSCAN7P1 RNA expression shows 6,986 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight SKCM, BRCA, and COAD as cancer lineages where ZKSCAN7P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZKSCAN7P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ZKSCAN7P1 survival associations across molecular data types. ZKSCAN7P1 RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZKSCAN7P1 RNA expression–survival associations across cancer types. High ZKSCAN7P1 expression shows unfavorable associations in SKCM, BLCA, STAD, LIHC, THCA and LUAD. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for ZKSCAN7P1 RNA expression.
This table summarizes ZKSCAN7P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for ZKSCAN7P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ZKSCAN7P1 shows lower tumor expression in BRCA and KIRC. The BRCA box plot shows higher ZKSCAN7P1 RNA expression in normal versus tumor tissue (log2 FC = −0.014, t-test p = .019).
This table shows molecular features associated with ZKSCAN7P1 in patient tissues and cancer cell lines. In patient samples, ZKSCAN7P1 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
